Spectral Medical Inc. (“ Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that it has filed a ...

The Dermatology Group of Arkansas are thrilled to welcome their newest, double board-certified specialist, Dr. Jessica Pillow, who joins the Little Rock, skin care-focused practice this summer. Dr.

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions Distinguished experts Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence ...

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN PATIENT SELECTION TARGETING POPULATION MOST LIKELY ...

L-Leucine (amount not specified): An essential amino acid, L-leucine helps preserve lean muscle mass during weight loss, ...

Located in La Rochelle, on the premises of a long-standing Spineway partner, the new line includes a clean room for injection operations. In line with the schedule 1, the first LP-ESP prostheses went ...

MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the ...

One employee received stock options to purchase an aggregate of 3,500 shares of Pacira common stock and seven employees received restricted stock units for an aggregate of 12,300 shares of Pacira ...

Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2025 second quarter results after market close on Tuesday, August 12, 2025. Nitin Jain, President and ...

Of the shares covered by the Options, one-third will vest on each of the first three anniversaries of the grant date, in each case for so long as the grantee provides continuous service to Anika ...

Contacts Investors Jenny Kobin Remy Bernarda IR Advisory Solutions [email protected] Media Kimberly Ha KKH Advisors 917-291-5744 [email protected] Source: Opus Genetics, Inc.